315 related articles for article (PubMed ID: 15564457)
21. The potential role of a late gene expression factor, lef2, from Bombyx mori nuclear polyhedrosis virus in very late gene transcription and DNA replication.
Sriram S; Gopinathan KP
Virology; 1998 Nov; 251(1):108-22. PubMed ID: 9813207
[TBL] [Abstract][Full Text] [Related]
22. The SWI/SNF Chromatin Regulator BRG1 Modulates the Transcriptional Regulatory Activity of the Epstein-Barr Virus DNA Polymerase Processivity Factor BMRF1.
Su MT; Wang YT; Chen YJ; Lin SF; Tsai CH; Chen MR
J Virol; 2017 May; 91(9):. PubMed ID: 28228591
[TBL] [Abstract][Full Text] [Related]
23. Isolation of the human interleukin 10 promoter. Characterization of the promoter activity in Burkitt's lymphoma cell lines.
Kube D; Platzer C; von Knethen A; Straub H; Bohlen H; Hafner M; Tesch H
Cytokine; 1995 Jan; 7(1):1-7. PubMed ID: 7749063
[TBL] [Abstract][Full Text] [Related]
24. Kaposi's sarcoma-associated herpesvirus lytic origin (ori-Lyt)-dependent DNA replication: identification of the ori-Lyt and association of K8 bZip protein with the origin.
Lin CL; Li H; Wang Y; Zhu FX; Kudchodkar S; Yuan Y
J Virol; 2003 May; 77(10):5578-88. PubMed ID: 12719550
[TBL] [Abstract][Full Text] [Related]
25. Kaposi's sarcoma-associated herpesvirus ori-Lyt-dependent DNA replication: cis-acting requirements for replication and ori-Lyt-associated RNA transcription.
Wang Y; Li H; Chan MY; Zhu FX; Lukac DM; Yuan Y
J Virol; 2004 Aug; 78(16):8615-29. PubMed ID: 15280471
[TBL] [Abstract][Full Text] [Related]
26. Immune activation suppresses initiation of lytic Epstein-Barr virus infection.
Ladell K; Dorner M; Zauner L; Berger C; Zucol F; Bernasconi M; Niggli FK; Speck RF; Nadal D
Cell Microbiol; 2007 Aug; 9(8):2055-69. PubMed ID: 17419714
[TBL] [Abstract][Full Text] [Related]
27. Induction of Epstein-Barr virus (EBV) reactivation in Raji cells by doxorubicin and cisplatin.
Hsu CH; Hergenhahn M; Chuang SE; Yeh PY; Wu TC; Gao M; Cheng AL
Anticancer Res; 2002; 22(6C):4065-71. PubMed ID: 12553034
[TBL] [Abstract][Full Text] [Related]
28. The lytic origin of herpesvirus papio is highly homologous to Epstein-Barr virus ori-Lyt: evolutionary conservation of transcriptional activation and replication signals.
Ryon JJ; Fixman ED; Houchens C; Zong J; Lieberman PM; Chang YN; Hayward GS; Hayward SD
J Virol; 1993 Jul; 67(7):4006-16. PubMed ID: 8389916
[TBL] [Abstract][Full Text] [Related]
29. Nuclear factor-Y and Epstein Barr virus in nasopharyngeal cancer.
Chia MC; Leung A; Krushel T; Alajez NM; Lo KW; Busson P; Klamut HJ; Bastianutto C; Liu FF
Clin Cancer Res; 2008 Feb; 14(4):984-94. PubMed ID: 18281530
[TBL] [Abstract][Full Text] [Related]
30. Promoter sequences required for reactivation of Epstein-Barr virus from latency.
Binné UK; Amon W; Farrell PJ
J Virol; 2002 Oct; 76(20):10282-9. PubMed ID: 12239304
[TBL] [Abstract][Full Text] [Related]
31. Regulation of Epstein-Barr virus BamHI-H divergent promoter by DNA methylation.
Nonkwelo CB; Long WK
Virology; 1993 Nov; 197(1):205-15. PubMed ID: 8212555
[TBL] [Abstract][Full Text] [Related]
32. Plasmid origin of replication of Epstein-Barr virus, oriP, does not limit replication in cis.
Sugden B; Warren N
Mol Biol Med; 1988 Apr; 5(2):85-94. PubMed ID: 2840551
[TBL] [Abstract][Full Text] [Related]
33. [Molecular mechanism of lytic phase of Epstein-Barr virus DNA replication].
Tsurumi T
Nihon Rinsho; 1997 Feb; 55(2):321-7. PubMed ID: 9046818
[TBL] [Abstract][Full Text] [Related]
34. Identification of a novel element involved in regulation of the lytic switch BZLF1 gene promoter of Epstein-Barr virus.
Kraus RJ; Mirocha SJ; Stephany HM; Puchalski JR; Mertz JE
J Virol; 2001 Jan; 75(2):867-77. PubMed ID: 11134300
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of nasopharyngeal carcinoma growth by RTA-expressing baculovirus vectors containing oriP.
Wang L; Shan L; Lo KW; Yin J; Zhang Y; Sun R; Zhong J
J Gene Med; 2008 Oct; 10(10):1124-33. PubMed ID: 18642396
[TBL] [Abstract][Full Text] [Related]
36. Epstein-Barr virus encoded BALF1 gene is transcribed in Burkitt's lymphoma cell lines and in nasopharyngeal carcinoma's biopsies.
Cabras G; Decaussin G; Zeng Y; Djennaoui D; Melouli H; Broully P; Bouguermouh AM; Ooka T
J Clin Virol; 2005 Sep; 34(1):26-34. PubMed ID: 16087121
[TBL] [Abstract][Full Text] [Related]
37. Mutant Cellular AP-1 Proteins Promote Expression of a Subset of Epstein-Barr Virus Late Genes in the Absence of Lytic Viral DNA Replication.
Lyons DE; Yu KP; Vander Heiden JA; Heston L; Dittmer DP; El-Guindy A; Miller G
J Virol; 2018 Oct; 92(19):. PubMed ID: 30021895
[TBL] [Abstract][Full Text] [Related]
38. The activation of lytic replication of Epstein-Barr virus by baculovirus-mediated gene transduction.
Wang L; Shan L; Yin J; Zhao M; Su D; Zhong J
Arch Virol; 2006 Oct; 151(10):2047-53. PubMed ID: 16673043
[TBL] [Abstract][Full Text] [Related]
39. Induction of the early growth response 1 gene by Epstein-Barr virus lytic transactivator Zta.
Chang Y; Lee HH; Chen YT; Lu J; Wu SY; Chen CW; Takada K; Tsai CH
J Virol; 2006 Aug; 80(15):7748-55. PubMed ID: 16840354
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of Epstein-Barr virus replication by small interfering RNA targeting the Epstein-Barr virus protease gene.
Larrat S; Morand P; Bas A; Vigne S; Crance JM; Boyer V; Nicod S; Grossi L; Buisson M; Burmeister WP; Seigneurin JM; Germi R
Antivir Ther; 2009; 14(5):655-62. PubMed ID: 19704168
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
